Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer

Familial Cancer

Volumn 8, Issue 4, 2009, Pages 479-482

  Edwards, Emma ^a   Yearwood, Catharina ^b   Sillibourne, Julie ^c   Baralle, Diana ^a   Eccles, Diana ^a  

^a PRINCESS ANNE HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c WESSEX REGIONAL GENETICS LABORATORY   (United Kingdom)

Author keywords

BRCA1; De novo mutation; Familial breast cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BRCA2 GENE; BREAST CANCER; CASE REPORT; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; BRCA1 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENES, BRCA1; HUMANS; MUTATION; PEDIGREE;

EID: 70449528422     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-009-9270-8     Document Type: Article

References (28)

1. McIntosh A, Shaw C, Evans G et al (2004) Clinical guidelines and evidence review for the classification and care of women at risk of familial breast cancer. National Collaborating Centre for Primary Care/University of Sheffield, London
2. B Newman H Mu LM Butler, et al. 1998 Frequency of breast cancer attributable to BRCA1 in a population-based series of American women JAMA 279 915 921 10.1001/jama.279.12.915 1:CAS:528:DyaK1cXitlyju7Y%3D 9544765 (Pubitemid 28136080)
3. H Anton-Culver PF Cohen ME Gildea, et al. 2000 Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer Eur J Cancer 36 1200 1208 10.1016/S0959-8049(00)00110-6 1:CAS:528:DC%2BD3cXksFCrsrw%3D 10882857 (Pubitemid 30407006)
4. K Syrjakoski P Vahteristo H Eerola, et al. 2000 Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients J Natl Cancer Inst 92 1529 1531 10.1093/jnci/92.18.1529 1:STN:280: DC%2BD3M%2Fmt1SktQ%3D%3D 10995809
5. Anglian Breast Cancer Study Group 2000 Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases Br J Cancer 83 1301 1308 10.1054/bjoc.2000.1407
6. D Ellis J Greenman S Hodgson, et al. 2000 Low prevalence of germline BRCA1 mutations in early onset breast cancer without a family history J Med Genet 37 792 794 10.1136/jmg.37.10.792 1:CAS:528:DC%2BD3cXnvVOis7g%3D 11183185
7. D Ford DF Easton J Peto 1995 Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence Am J Hum Genet 57 1457 1462 1:CAS:528:DyaK28XktFSisw%3D%3D 8533776
8. M Clementi G Barbujani L Turolla, et al. 1990 Neurofibromatosis-1: a maximum likelihood estimation of mutation rate Hum Genet 84 116 118 10.1007/BF00208923 1:STN:280:DyaK3c7ivV2rtA%3D%3D 2105266
9. M Upadhyaya E Majounie P Thompson, et al. 2003 Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1 Hum Genet 112 12 17 10.1007/s00439-002-0840-1 1:CAS:528:DC%2BD3sXit1Oqs7Y%3D 12483293 (Pubitemid 36869109)
10. DM Milewicz M Duvic 1994 Severe neonatal Marfan syndrome resulting from a de novo 3-bp insertion into the fibrillin gene on chromosome 15 Am J Hum Genet 54 447 453 1:STN:280:DyaK2c7mtV2qsA%3D%3D 8116614
11. P Booms AP Withers M Boxer, et al. 1997 A novel de novo mutation in exon 14 of the fibrillin-1 gene associated with delayed secretion of fibrillin in a patient with a mild Marfan phenotype Hum Genet 100 195 200 10.1007/s004390050489 1:CAS:528:DyaK2sXkslGntLY%3D 9254848 (Pubitemid 27338789)
12. A Tesoriero C Andersen M Southey, et al. 1999 De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation Am J Hum Genet 65 567 569 10.1086/302503 1:STN:280:DyaK1Mzksl2lsA%3D%3D 10417300 (Pubitemid 30463015)
13. RB van der Luijt PH van Zon RP Jansen, et al. 2001 De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer J Med Genet 38 102 105 10.1136/jmg.38.2.102 11158174
14. M Robson L Scheuer K Nafa, et al. 2002 Unique de novo mutation of BRCA2 in a woman with early onset breast cancer J Med Genet 39 126 128 10.1136/jmg.39.2.126 1:CAS:528:DC%2BD38XitV2iur8%3D 11836363
15. DG Evans DM Eccles N Rahman, et al. 2004 A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO J Med Genet 41 474 480 10.1136/jmg.2003.017996 1:CAS:528: DC%2BD2cXlsl2gsbc%3D 15173236
16. G Parmigiani D Berry O Aguilar 1998 Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2 Am J Hum Genet 62 145 158 10.1086/301670 1:CAS:528:DyaK1cXhsVGrsrc%3D 9443863 (Pubitemid 28093844)
17. Hopper JL, Chenevix-Trench G, Jolley DJ et al (1999) Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). J Natl Cancer Inst Monogr 26:95-100
18. MC Southey AA Tesoriero CR Andersen, et al. 1999 BRCA1 mutations and other sequence variants in a population-based sample of Australian women with breast cancer Br J Cancer 79 34 39 10.1038/sj.bjc.6690008 1:CAS:528: DyaK1MXmvVKlsQ%3D%3D 10408690 (Pubitemid 28566923)
19. J Peto N Collins R Barfoot, et al. 1999 Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer J Natl Cancer Inst 91 943 949 10.1093/jnci/91.11.943 1:CAS:528:DyaK1MXjvFOmtb4%3D 10359546
20. KE Malone JR Daling JD Thompson, et al. 1998 BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history JAMA 279 922 929 10.1001/jama.279.12.922 1:CAS:528:DyaK1cXitlyju7c%3D 9544766 (Pubitemid 28136081)
21. KE Malone JR Daling C Neal, et al. 2000 Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases Cancer 88 1393 1402 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0. CO;2-P 1:CAS:528:DC%2BD3cXisVentr0%3D 10717622 (Pubitemid 30155177)
22. N Loman O Johannsson U Kristoffersson, et al. 2001 Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer J Natl Cancer Inst 93 1215 1223 10.1093/jnci/93.16.1215 1:CAS:528:DC%2BD3MXms1OrtLc%3D 11504767
23. de Sanjosé S, Leone M, Berez V et al (2003) Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study. Int J Cancer 106:588-93
24. J Plaschke T Commer C Jacobi, et al. 2000 BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease J Med Genet 37 E17 10.1136/jmg.37.9.e17 1:STN:280:DC%2BD3M%2FitlKlsw%3D%3D 10978364
25. V Bonadona OM Sinilnikova S Chopin, et al. 2005 Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France Genes Chromosomes Cancer 43 404 413 10.1002/gcc.20199 1:CAS:528:DC%2BD2MXlvFCku78%3D 15887246 (Pubitemid 40946475)
26. DH Choi MH Lee AE Bale, et al. 2004 Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients J Clin Oncol 22 1638 1645 10.1200/JCO.2004.04.179 1:CAS:528:DC%2BD2cXpsVWmu7c%3D 15117986 (Pubitemid 41079802)
27. M Loizidou Y Marcou V Anastasiadou, et al. 2007 Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus Clin Genet 71 165 170 10.1111/j.1399-0004.2007.00747.x 1:STN:280:DC%2BD2s%2FkslClsA%3D%3D 17250666 (Pubitemid 46189221)
28. SR Lakhani JS Reis-Filho L Fulford, et al. 2005 Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype Clin Cancer Res 11 5175 5180 10.1158/1078-0432.CCR-04-2424 1:CAS:528:DC%2BD2MXmt12qtbk%3D 16033833 (Pubitemid 41003703)